Fisher & Paykel Healthcare Corporation Limited (FPH.AX)
AUD 33.88
(-1.83%)
AUD 33.88
(-1.83%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 107.1 Million NZD | 361.4% |
| 2023 | 23.21 Million NZD | 74.03% |
| 2022 | 13.33 Million NZD | -31.25% |
| 2021 | 19.4 Million NZD | -71.01% |
| 2020 | 66.93 Million NZD | 82.98% |
| 2019 | 36.57 Million NZD | -22.98% |
| 2018 | 47.49 Million NZD | 24780.33% |
| 2017 | -192.43 Thousand NZD | -100.48% |
| 2016 | 40.07 Million NZD | -22.75% |
| 2015 | 51.87 Million NZD | -47.56% |
| 2014 | 98.91 Million NZD | -22.0% |
| 2013 | 126.81 Million NZD | 16.89% |
| 2012 | 108.48 Million NZD | 16.73% |
| 2011 | 92.93 Million NZD | 20.35% |
| 2010 | 77.22 Million NZD | -33.14% |
| 2009 | 115.49 Million NZD | 42.85% |
| 2008 | 80.85 Million NZD | 144.24% |
| 2007 | 33.1 Million NZD | 354.27% |
| 2006 | 7.28 Million NZD | 148.61% |
| 2005 | -14.99 Million NZD | 33.08% |
| 2004 | -22.4 Million NZD | -118.98% |
| 2003 | -10.23 Million NZD | 84.1% |
| 2002 | -64.33 Million NZD | 29.98% |
| 2001 | -91.88 Million NZD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 219.12 Million NZD | 0.0% |
| 2024 FY | 107.1 Million NZD | 361.4% |
| 2024 Q4 | 107.1 Million NZD | 0.0% |
| 2023 Q4 | 24.8 Million NZD | 0.0% |
| 2023 Q2 | 72.59 Million NZD | 0.0% |
| 2023 FY | 23.21 Million NZD | 74.03% |
| 2022 Q4 | 14.4 Million NZD | 0.0% |
| 2022 Q2 | -3.24 Million NZD | 0.0% |
| 2022 FY | 13.33 Million NZD | -31.25% |
| 2021 FY | 19.4 Million NZD | -71.01% |
| 2021 Q2 | 5.82 Million NZD | 0.0% |
| 2021 Q4 | 21.1 Million NZD | 0.0% |
| 2020 Q4 | 69.1 Million NZD | 0.0% |
| 2020 Q2 | 69.11 Million NZD | 0.0% |
| 2020 FY | 66.93 Million NZD | 82.98% |
| 2019 Q2 | 37.14 Million NZD | 0.0% |
| 2019 FY | 36.57 Million NZD | -22.98% |
| 2019 Q4 | 38.1 Million NZD | 0.0% |
| 2018 FY | 47.49 Million NZD | 24780.33% |
| 2018 Q2 | 26.39 Million NZD | 0.0% |
| 2018 Q4 | 50.5 Million NZD | 0.0% |
| 2017 Q4 | -259 Thousand NZD | 0.0% |
| 2017 FY | -192.43 Thousand NZD | -100.48% |
| 2017 Q2 | 49.15 Million NZD | 0.0% |
| 2016 Q2 | 103.35 Million NZD | 0.0% |
| 2016 FY | 40.07 Million NZD | -22.75% |
| 2016 Q4 | 44.39 Million NZD | 0.0% |
| 2015 Q2 | 95.34 Million NZD | 0.0% |
| 2015 Q4 | 51.87 Million NZD | 0.0% |
| 2015 FY | 51.87 Million NZD | -47.56% |
| 2014 Q4 | 98.91 Million NZD | 1129.04% |
| 2014 Q3 | -9.61 Million NZD | -106.71% |
| 2014 FY | 98.91 Million NZD | -22.0% |
| 2014 Q1 | -5.78 Million NZD | -104.56% |
| 2014 Q2 | 143.17 Million NZD | 2574.58% |
| 2013 Q3 | -6.12 Million NZD | -51.84% |
| 2013 Q2 | -4.03 Million NZD | -1.83% |
| 2013 Q1 | -3.96 Million NZD | -103.65% |
| 2013 Q4 | 126.81 Million NZD | 2168.79% |
| 2013 FY | 126.81 Million NZD | 16.89% |
| 2012 FY | 108.48 Million NZD | 16.73% |
| 2012 Q4 | 108.48 Million NZD | 0.0% |
| 2011 FY | 92.93 Million NZD | 20.35% |
| 2011 Q4 | 92.93 Million NZD | 0.0% |
| 2010 FY | 77.22 Million NZD | -33.14% |
| 2010 Q4 | 77.22 Million NZD | 0.0% |
| 2009 Q4 | 115.49 Million NZD | 0.0% |
| 2009 FY | 115.49 Million NZD | 42.85% |
| 2008 Q4 | 80.85 Million NZD | 0.0% |
| 2008 FY | 80.85 Million NZD | 144.24% |
| 2007 Q4 | 33.1 Million NZD | 0.0% |
| 2007 FY | 33.1 Million NZD | 354.27% |
| 2006 Q4 | 7.28 Million NZD | 0.0% |
| 2006 FY | 7.28 Million NZD | 148.61% |
| 2005 Q4 | -14.99 Million NZD | 0.0% |
| 2005 FY | -14.99 Million NZD | 33.08% |
| 2004 Q4 | -22.4 Million NZD | 0.0% |
| 2004 FY | -22.4 Million NZD | -118.98% |
| 2003 Q4 | -10.23 Million NZD | 0.0% |
| 2003 FY | -10.23 Million NZD | 84.1% |
| 2002 FY | -64.33 Million NZD | 29.98% |
| 2001 FY | -91.88 Million NZD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Austco Healthcare Limited | -13.47 Million AUD | 894.746% |
| Nanosonics Limited | -120.24 Million AUD | 189.065% |
| Osteopore Limited | -116.05 Thousand AUD | 92387.012% |
| SDI Limited | 16.84 Million AUD | -535.872% |
| Trajan Group Holdings Limited | 44.92 Million AUD | -138.424% |